Novartis AG (NVS)
160.50
+0.25
(+0.16%)
USD |
NYSE |
Nov 13, 16:00
160.52
+0.02
(+0.01%)
After-Hours: 19:59
Novartis Price : 160.50 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 160.11 | 160.84 | 159.48 | 160.50 | 1.417M |
| Nov 12, 2026 | 160.98 | 161.32 | 159.93 | 160.25 | 2.138M |
| Nov 11, 2026 | 159.64 | 160.68 | 159.20 | 160.32 | 2.322M |
| Nov 10, 2026 | 162.60 | 164.18 | 162.36 | 163.26 | 1.979M |
| Nov 09, 2026 | 163.73 | 164.18 | 161.52 | 163.69 | 2.318M |
| Nov 06, 2026 | 159.40 | 163.11 | 159.36 | 162.55 | 1.996M |
| Nov 05, 2026 | 163.24 | 165.96 | 161.65 | 161.93 | 2.440M |
| Nov 04, 2026 | 163.69 | 165.05 | 162.16 | 164.98 | 1.745M |
| Nov 03, 2026 | 161.30 | 161.79 | 158.92 | 159.26 | 1.343M |
| Nov 02, 2026 | 160.54 | 161.87 | 160.11 | 161.52 | 1.547M |
| Oct 30, 2026 | 162.53 | 164.06 | 160.40 | 160.79 | 3.153M |
| Oct 29, 2026 | 160.68 | 162.19 | 159.91 | 161.10 | 2.237M |
| Oct 28, 2026 | 154.86 | 157.41 | 154.11 | 156.08 | 1.945M |
| Oct 27, 2026 | 154.15 | 156.98 | 154.13 | 156.86 | 3.734M |
| Oct 26, 2026 | 153.52 | 154.24 | 152.02 | 153.81 | 2.816M |
| Oct 23, 2026 | 156.08 | 156.08 | 149.17 | 151.12 | 4.359M |
| Oct 22, 2026 | 154.90 | 157.10 | 154.38 | 156.27 | 2.081M |
| Oct 21, 2026 | 153.12 | 154.12 | 152.93 | 153.93 | 1.019M |
| Oct 20, 2026 | 152.15 | 153.68 | 151.95 | 153.64 | 1.357M |
| Oct 19, 2026 | 150.22 | 150.90 | 149.62 | 150.20 | 1.867M |
| Oct 16, 2026 | 150.65 | 151.74 | 150.23 | 150.62 | 1.729M |
| Oct 15, 2026 | 150.32 | 151.83 | 149.64 | 150.38 | 2.090M |
| Oct 14, 2026 | 144.35 | 147.16 | 144.17 | 146.88 | 1.647M |
| Oct 13, 2026 | 145.18 | 145.24 | 142.31 | 142.41 | 1.841M |
| Oct 12, 2026 | 143.84 | 144.02 | 143.12 | 143.84 | 1.150M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Roche Holding AG | 60.30 |
| AstraZeneca PLC | 184.45 |
| GSK Plc | 50.45 |
| Johnson & Johnson | 285.75 |
| Eli Lilly & Co. | 1443.50 |
Price Related Metrics
| PE Ratio | 30.65 |
| PS Ratio | 5.556 |
| Price to Book Value | 8.142 |
| Price to Free Cash Flow | 21.98 |
| Earnings Yield | 3.26% |
| Market Cap | 303.12B |
| Operating PE Ratio | 18.23 |
| Normalized PE Ratio | 24.40 |